Arrowstreet Capital’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Arrowstreet Capital’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-61,168	Closed	-$1.07M	–	2679
2020 Q4	$1.07M	Sell	61,168 -59,500	-49%	-$835K	﹤0.01%	1810
2020 Q3	$1.41M	Buy	+120,668	New	+$1.6M	﹤0.01%	1699
2020 Q1	–	Sell	-14,251	Closed	-$237K	–	2227
2019 Q4	$237K	Buy	+14,251	New	+$231K	﹤0.01%	1602
2019 Q2	–	Sell	-28,500	Closed	-$491K	–	1854
2019 Q1	$491K	Buy	+28,500	New	+$451K	﹤0.01%	1482

Arrowstreet Capital's OXFD Position: Q1 2021 in Review

Arrowstreet Capital sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 61,168 shares — an estimated $1.07M sold.

Arrowstreet Capital first reported a position in OXFD in Q1 2019 and held it in 4 quarters. The position peaked at $1.41M in Q3 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Arrowstreet Capital reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Arrowstreet Capital sold 61,168 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.07M.
Arrowstreet Capital first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 4 quarters.
Arrowstreet Capital's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.41M in Q3 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.